Hi [[ session.user.profile.firstName ]]

Enabling CAR-T Screening in 3D Tumor Spheroids

Webinar Date & Time: Mar 30 2017 12:00 p.m. EST

Chimeric antigen receptor (CAR)-T cells, which are engineered to recognize target cell surface antigens expressed on tumor cells, have shown promise to affect complete remission in patients with B-cell malignancies. However, applying this approach to target solid tumors has resulted in adverse effects in clinical studies. Methods for testing different models of CAR-T cells in vitro can provide further insight into viable antigen targets. Historically, two-dimensional (2D) cell culture models have been used in drug discovery. However, more elaborate, three-dimensional (3D) cell culture models better mimic the in vivo tumor microenvironment and help bridge the gap between in vitro studies and clinical outcomes.

In this special joint webinar, panelists from ProMab Biotechnologies, DiscoverX, and Corning Life Sciences will present data on a high-throughput, easy-to-use, highly reproducible method for screening CAR-T cells in a 3D cell culture model by combining various technologies.


Speakers:
Van Dang, D.V.M., Ph.D.
Scientist and coordinator for CAR-T research
ProMab Biotechnologies, Inc.

Abhi Saharia, Ph. D.
Director, Cell-based Assays and Biologics
DiscoverX

Audrey Bergeron
Applications Scientist
Corning Life Sciences
Recorded Mar 30 2017 62 mins
Your place is confirmed,
we'll send you email reminders
Presented by
Van Dang, D.V.M., Ph.D., Abhi Saharia, Ph. D., and Audrey Bergeron, Applications Scientist
Presentation preview: Enabling CAR-T Screening in 3D Tumor Spheroids

Network with like-minded attendees

  • [[ session.user.profile.displayName ]]
    Add a photo
    • [[ session.user.profile.displayName ]]
    • [[ session.user.profile.jobTitle ]]
    • [[ session.user.profile.companyName ]]
    • [[ userProfileTemplateHelper.getLocation(session.user.profile) ]]
  • [[ card.displayName ]]
    • [[ card.displayName ]]
    • [[ card.jobTitle ]]
    • [[ card.companyName ]]
    • [[ userProfileTemplateHelper.getLocation(card) ]]
  • Channel
  • Channel profile
  • Advanced Trends and Tools for Gene Therapy Apr 29 2021 3:00 pm UTC 45 mins
    Constanza Curotto
    Once considered conceptual, gene therapy has now become a reality, and as this therapy becomes more widely adopted, the need for larger batch sizes will ultimately conflict with the amount of available space in clean rooms. Building on a long and expert history in cell culture, Corning offers viral vector manufacturing platforms that are easily integrated into modular production set-ups, such as Corning® HYPERStack® and CellSTACK® vessels, which are enabling viral vectors to be produced at large scales. This seminar will introduce you to the new tools and solutions that Corning has developed for this field, as well as applications related to viral vector production.

    Presenter bio:
    After graduating from Biochemistry from the University of Santiago (Chile), Constanza perused a career in the Chilean animal health industry, developing as a Bioprocess Scientist for vaccine production in charge of scale-up and tech transfer. She furthered developed her career in Belgium, in the field of antibody production in suspension cell lines. Constanza is currently a Field Application Scientist for the EMEA region, providing customers in-depth technical support, presenting seminars and trainings, and assisting customers in experimental set-up and troubleshooting.
  • Advanced Trends and Tools for Stem Cell Therapy Apr 13 2021 3:00 pm UTC 45 mins
    Constanza Curotto
    The science of stem cell culture has advanced rapidly since its beginnings in the 1980s, as has the technology behind this research. From feeder-free substrates, to defined media, to scalable cell expansion systems, continual advances in stem cell culture have inspired Corning to develop innovative new tools to support this groundbreaking work and help overcome the challenges that has limited widespread adoption to date. This webinar will cover Corning’s new tools and solutions that enable the advancement of this area of research with specialized vessels, surfaces, and media to keep pushing the boundaries of what is possible.

    Presenter bio:
    After graduating from Biochemistry from the University of Santiago (Chile), Constanza perused a career in the Chilean animal health industry, developing as a Bioprocess Scientist for vaccine production in charge of scale-up and tech transfer. She furthered developed her career in Belgium, in the field of antibody production in suspension cell lines. Constanza is currently a Field Application Scientist for the EMEA region, providing customers in-depth technical support, presenting seminars and trainings, and assisting customers in experimental set-up and troubleshooting.
  • Advanced Trends and Tools for Immune Cell Therapy Mar 30 2021 3:00 pm UTC 45 mins
    Constanza Curotto
    With key advancements in cancer immunotherapies, the need for autologous T-cell manufacturing technologies that cost-effectively scale from pre-clinical to commercial production is becoming critical. Leveraging our long and expert history in cell culture, Corning is driving the development of clinical cell expansion platforms designed to reduce manufacturing time and drive down production costs. This seminar will introduce you to the new tools and solutions that Corning has developed for the field of immune cell therapy, as well as applications related to CAR-T therapies.

    Presenter bio:
    After graduating from Biochemistry from the University of Santiago (Chile), Constanza perused a career in the Chilean animal health industry, developing as a Bioprocess Scientist for vaccine production in charge of scale-up and tech transfer. She furthered developed her career in Belgium, in the field of antibody production in suspension cell lines. Constanza is currently a Field Application Scientist for the EMEA region, providing customers in-depth technical support, presenting seminars and trainings, and assisting customers in experimental set-up and troubleshooting.
  • Advancing Neurosphere Research with 3D Cell Culture Recorded: Feb 16 2021 49 mins
    Roxana Ghadessy, Ph.D.
    Neurosphere formation of human neural stem cells (hNSCs) is a widely used in vitro culture system to study neurogenesis, neural development, neurotoxicity, and neurodegenerative disease models. This system allows for three-dimensional (3D) expansion of hNSCs within a more physiologically relevant microenvironment. Having an easy-to-use, reproducible neurosphere culture and analysis method to understand hNSC dynamics greatly enables their use for drug discovery and cell therapy applications. In this webinar, learn how Corning® spheroid microplates provide an ideal tool to study neurosphere formation, proliferation, differentiation, migration, and neurotoxicity of hNSCs, in an easy-to-use format amenable to high throughput screening.

    Presenter bio
    Roxana Ghadessy is a Technical Marketing Manager for Corning Life Sciences, based in Singapore. In this role she is responsible for product awareness and education activities to highlight Corning’s workflow solutions in cell culture, drug discovery, and other differentiated applications. Roxana has held previous roles in Sales and Product Management at Corning, BD Biosciences, and Tocris. She received her Ph.D. degree in Pharmacology from the University of Bristol.
  • Neuroscience Applications with 3D Cell Culture Recorded: Feb 4 2021 45 mins
    Constanza Curotto
    Countless medical breakthroughs over the past century have begun with two-dimensional (2D) cell culture models. However, the limitations of 2D culture are immediately obvious – cells, tissues, and organs exist in three dimensions, not two, and tissues almost always consist of more than one cell type. By providing greater physiologic relevance, 3D cultures narrow the bridge between in vitro and live-animal or human assays. Recently, advances in the development of 3D brain cell culture models are recapitulating various aspects of the human brain physiology in vitro, used to replicate various disease processes. This webinar will cover the basics of 3D models applied to Neuroscience, including models for neurosphere and blood brain barrier generation.

    Presenter bio
    After graduating from Biochemistry in the University of Santiago (Chile), Constanza pursued directly a career in the Chilean Vaccine R&D industry, developing as a bioprocess scientist for both bacterial and viral vaccines in the field of animal health, being in charge of scale-up, and tech transfer with manufacturing plants. She furthered developed her career in Belgium as a bioprocess scientist, this time in the field of recombinant protein production, pursuing protocol optimization and scale-up experiments with suspension mammalian cell lines. Constanza is currently a field applications scientist in Corning for the EMEA region, providing customers with in-depth technical support, presenting seminars and trainings, and assisting customers in experimental set-up and troubleshooting.
  • Corning® HYPER Technologies: Compact Solutions for Cell Culture Scale-up Recorded: Jan 28 2021 45 mins
    Catherine Siler, Ph.D
    Introduction: 00:00 – 2:28
    Requirements for culturing adherent cells: 2:29 – 3:43
    HYPER Technology - Specifications and Performance Analysis: 3:44 - 12:31
    Applications and Workflow: 12:32 – 22:56
    Complementary Solutions – Single-use Systems, Custom Solutions, and Manipulator: 22:57 – 32:54
    Q&A Session: 33:27 – 44:12

    The scale-up process for recombinant viral vector production presents technical challenges, including optimizing cellular output within constraints of facility space and operator time. Using an ultra-thin gas-permeable film, the Corning® HYPERStack® vessel is able to provide up to 10X the growth surface area of a traditional cell culture vessel of comparable footprint. This provides an efficient, scalable cell culture vessel for adherent cell culture processes common to gene and cell therapy applications. This webinar will introduce viewers to the Corning High Yield PERformance technology platform, with attention to the following topics:
    •Introduction to the technical applications of the HYPERStack vessel in the fields of cell and gene therapy and viral particle production
    •HYPER technology background – cells and requirements for culture
    •The advantages of a closed system design ideal for the production of cells, protein therapeutics, vaccines, and viral vectors, including those targeting Coronavirus and COVID-19


    Presenter:
    Dr. Catherine Siler graduated from Johns Hopkins University with a Ph.D. in Biology. Dr. Siler also has several years of experience as a Bioprocess Sales Specialist with Corning, focusing on custom media and closed system solutions. Currently, Dr. Siler is part of the Field Applications team, covering the Northeast corridor and assisting customers with 3D cell culture techniques, cell and gene therapy processes, and general bioprocessing applications.
  • Replay: 3D Cell Culture and the Quest for Effective NASH/NAFLD Solution Recorded: Dec 16 2020 45 mins
    Tim Baranowski, Ph.D.,Field Applications Scientist at Molecular Devices and Erin Edwards, Ph.D., Head of Services at Visiko
    For this previously recorded webinar, we partnered with Molecular Devices and Visikol to show how integrating novel 3D cell culture, tissue clearing, and high-content imaging techniques can better identify therapeutic solutions to NASH/NAFLD.

    Learn how to:
    •Increase assay sensitivity and viability using Primary Human Hepatocytes (PHH) pre-qualified for spheroid formation
    •Apply tissue clearing techniques to fully characterize 3D cell culture models in a single workflow
    •Utilize water immersion objectives and targeted acquisition with confocal imaging to fully characterize 3D fibrosis models in a high throughput manner
    •Perform 3D volumetric analysis and other custom analyses for unique feature extraction and quantification
  • Replay: Using Organoids for COVID-19 Disease Models and Organoid Best Practices Recorded: Dec 15 2020 54 mins
    Shuibing Chen, Ph.D,Weill Cornell Medicine | Austin Mogen, Ph.D,Senior Field Application Scientist
    3D cell culture techniques are emerging as versatile and biologically relevant research models to help support the current fight against COVID-19. Learn how a research team from Weill Cornell Medicine developed a lung organoid model using human pluripotent stem cells (hPSC-LOs) as well as complementary hPSC-derived colonic organoids (hPSC-COs) to study SARS-CoV-2 infectivity and immune responses, and as tools for antiviral drug discovery and development. You'll also learn technologies, methods, and best practices for culturing organoids
  • 3D Cell Cultures and Tissue Clearing Recorded: Nov 25 2020 51 mins
    Ian MacCloud, Laboratory Manager at Visikol Inc. and Dr. Ann Rossi Bilodeau, Corning Life Sciences
    There are many important considerations for how best to image a 3D cell culture model. Moreover, there are numerous high content imaging systems available. This webinar reviews some of the systems available,best practices when imaging 3D cell culture models, and how to employ tissue clearing for improved imaging. Additionally, the presenters share several case studies in which tissue clearing and high content confocal microscopy are integral to addressing specific research questions:
    • LED vs. laser illumination
    • Dipping vs. air objectives
    • Basic principles of confocal microscopy
    • Best practices for labeling 3D cell culture models
    • Wide field vs. confocal imaging
    • 3D image analysis

    Webinar Highlights:
    - Introduction: 00:00 - 3:18
    - The State of 3D Cell Culture: 3:19 - 8:19
    - Tissue Clearing and Labeling Techniques for 3D-CCM: 8:20 - 17:20
    - High Content Imaging Considerations: 17:21 - 28:07
    - Workflow and Case Study - 3D Cell Culture Models for Immunoncology: 28:08 -38:14
    - Q&A Session: 38:15 - 51:48
  • COVID-19: Insights Through 3D Cell Culture Recorded: Nov 19 2020 53 mins
    Dr. Xiaoyu Zhu
    3D cell culture techniques are emerging as versatile and biologically relevant research models to help support the current fight against COVID-19. This webinar will summarize insights on how air-liquid interface and airway organoid cultures can be used as experimental virology platforms to study SARS-CoV-2 infectivity and immune responses, and as tools for antiviral drug discovery and development. Recent data from Corning on the characterization of an airway organoid model for COVID-19 drug screening using the Corning® Matrigel® Matrix 3D-plate will also be presented.
  • マイクロキャリアを用いた幹細胞増殖およびウイルスベクター産生の培養事例の紹介 Recorded: Nov 17 2020 61 mins
    コーニングインターナショナル株式会社  ライフサイエンス事業部 石渡 孝至
    細胞治療用細胞やベクター産生の産業応用への期待が高まるにつれ、生存細胞を最大効率で回収することが求められています。そこでシングルユース製品のマイクロキャリアに ついて細胞培養事例を含めて概説します。
  • SARS-CoV-2: Insights Through 3D Cell Culture Recorded: Oct 20 2020 58 mins
    Roxana Ghadessy Ph.D. and Claire Zhang Ph.D.
    3D cell culture techniques are emerging as versatile and biologically relevant research models to help support the current fight against COVID-19. This webinar will summarize insights on how air-liquid interface and airway organoid cultures can be used as experimental virology platforms to study SARS-CoV-2 infectivity and immune responses, and as tools for antiviral drug discovery and development. Recent data from Corning on the characterization of an airway organoid model for COVID-19 drug screening using the Corning® Matrigel® Matrix 3D-plate will also be presented.
  • Bacteriological Analysis of Water Recorded: Oct 14 2020 40 mins
    Mourad Ferhat,Ph.D.
    Waterborne diseases are a leading cause of death and a global concern. Bacteriological analysis of water is one of the 3 parameters when assessing water safety. With the COVID 19 pandemic, bacteriological monitoring of water quality has become crucial for safely re-opening academia and industry. It also opens new possibilities such as the use of bacteriological analysis to detect early signs of a future outbreak.

    In this webinar you will learn:
    - Critical parameters for controlling water quality
    - Bacteriological analysis techniques and standard methods for bacterial enumeration
    - Legionella risk and how to control it
    - Tips for proper water sample collection, handling, and identification
    - Corning solutions for water sampling, testing, and analysis


    Speaker Bio:
    Mourad Ferhat, Ph.D.,
    After receiving a License in Genetics and a Master’s degree in molecular and cellular biology applied to oncology, Mourad received his Ph.D. from the University of Lyon in 2006 where he studied host-pathogen interactions to discover new mechanisms involved in the phenotypic switch of Legionella pneumophila. After many years of experience in industry, mainly with diagnostic and life sciences companies, he joined Corning in 2019 as Product Manager for the Microbiology and Liquid Handling portfolios in EMEA.
  • 間葉系幹細胞から血小板製造:再生医療等製品のトランスレーショナルリサーチ Recorded: Oct 14 2020 68 mins
    慶應義塾大学医学部臨床研究推進センター    特任准教授 松原 由美子 先生
    血小板は輸血や組織修復で医療応用されていますが、ドナー依存等の問題があります。私たちは基礎研究成果に基づいて、ドナーに依存しない血小板を間葉系幹細胞から遺伝子導入を必要としないシンプルな製造システムで得られる再生医療等製品の開発を行っており、その概要をご紹介いたします。
  • Maximizing Cell Yields Using Perfusion Recorded: Oct 1 2020 35 mins
    Dr. Ann Rossi Bilodeau
    Progress in cell and gene therapy research will accelerate clinical cell therapy programs in the coming years. As cell therapy trials advance from pre-clinical to late-stage trials, cell culture platforms will need to meet increasing demands for cell yield.

    In this webinar, Dr. Ann Rossi Bilodeau:
    •Shares data supporting efficient expansion of HEK293T and Vero cells
    •Demonstrates how the Corning® CellCube® system provides a simple, compact, and scalable method for mass culture of attachment-dependent cells
    •Shows you can achieve yields of greater than 10 billion cells with efficient medium usage

    00:00 - 01:30: Introduction
    1:31 - 7:50: Considerations and challenges for scaling adherent cell growth
    7:51 - 14:07: Corning® CellCube® Culture System
    14:08 - 24:30: Case Study - HEK293T and Vero Cell Expansion
    24:31 - 34:30: Q&A Session

    About the Presenter:
    Dr. Ann Rossi Bilodeau graduated from the University of Rochester School of Medicine and Dentistry with a Ph.D. in Pharmacology and received postdoctoral training at the University of Chicago. Ann began her career with Corning Life Sciences as the Applications Lab Manager where she utilized her strong academic and industry research experience to direct the activities of the Applications Laboratory. Currently, Dr. Rossi Bilodeau is the Senior Bioprocess Applications Scientist, functioning as the technical lead for generating applications in support of Corning Life Sciences’ Bioprocess and Cell/Gene Therapy portfolios including CellCube and HYPERStack platforms.
  • Epithelial Barrier Homeostasis and Response to Infections Recorded: Sep 29 2020 59 mins
    Dr. Francesco Boccellato
    The forefront of the gastrointestinal mucosa consists mainly of a continuous polarized epithelial monolayer protected by mucus. This strong defense barrier can be colonized by pathogens arousing a chronic inflammatory state. This exceptional colonization ability is associated with an increased risk of developing adenocarcinomas at the sites of infection. We have regenerated functional epithelial monolayers in vitro. These mucosoid cultures are human multi-lineage stem cell-based in vitro-equivalent of a real mucosa. They mimic the function of a homeostatic epithelial barrier including accumulation of mucus on the apical side. Use of human mucosoid cultures reveals novel insight into epithelial homeostasis and response to bacterial infection.

    About the presenter:
    Dr. Francesco Boccellato studied at Sapienza University of Rome. Ever since he was a student, he's been interested in the impact of pathogens in causing cancer in humans. During his Ph.D. in Rome, he studied the role of the Epstein - Barr virus (EBV) in deregulating microRNAs in diffuse large B cell lymphomas. After his Ph.D., Francesco moved to Berlin to the Max Planck Institute for Infection Biology, were he became interested in the causality of bacterial infection in human cancers. To study the impact of infection on healthy epithelial barriers Francesco invented a new cultivation systems for healthy epithelial cells called the mucosoids. The mucosoids are monolayers of polarised epithelial cells that recapitulate all the functions of an epithelial barrier in the body, including mucus production. Francesco recently started his independent group in the University of Oxford (UK) at the Ludwig Institute for Cancer Research.
  • 3D Cell Cultures and Tissue Clearing Recorded: Sep 24 2020 52 mins
    Ian MacCloud, Laboratory Manager at Visikol Inc. and Dr. Ann Rossi Bilodeau, Corning Life Sciences
    There are many important considerations for how best to image a 3D cell culture model. Moreover, there are numerous high content imaging systems available. This webinar reviews some of the systems available,best practices when imaging 3D cell culture models, and how to employ tissue clearing for improved imaging. Additionally, the presenters share several case studies in which tissue clearing and high content confocal microscopy are integral to addressing specific research questions:
    • LED vs. laser illumination
    • Dipping vs. air objectives
    • Basic principles of confocal microscopy
    • Best practices for labeling 3D cell culture models
    • Wide field vs. confocal imaging
    • 3D image analysis

    Webinar Highlights:
    - Introduction: 00:00 - 3:18
    - The State of 3D Cell Culture: 3:19 - 8:19
    - Tissue Clearing and Labeling Techniques for 3D-CCM: 8:20 - 17:20
    - High Content Imaging Considerations: 17:21 - 28:07
    - Workflow and Case Study - 3D Cell Culture Models for Immunoncology: 28:08 -38:14
    - Q&A Session: 38:15 - 51:48
  • Qualidade e Acreditação em Laboratorios - Uma abordagem da influência do vidro Recorded: Sep 17 2020 76 mins
    Jerónimo Figueiredo
    Qualidade e Acreditação em Laboratorios - Uma abordagem da influência da vidraria
    Jerónimo Figueiredo - Business Operations Manager
  • HUB Organoids™: Impacting Clinical Outcomes Using Organoid Disease Models Recorded: Sep 17 2020 45 mins
    Jasper Mullenders, Ph.D.
    Learn how our guest presenter is using organoid models to predict patient response and provide access to patients to treatments for Cystic Fibrosis.
    This webinar covers:
    • HUB organoids as a predictive diagnostics tool to identify the right treatment for each individual patient
    • Challenges and opportunities when working with tumor models
    • How organoid biobanks provide a unique in vitro system for screening the efficacy of both approved drugs and compounds in preclinical environment

    Webinar highlights:
    - Introduction: 00:00 - 2:23
    - HUB Organoids - Adult Stem Cell-Derived Organoids: 2:24 - 7:55
    - Using organoid models to predict patient response and provide access to patients to treatments for Cystic Fibrosis: 7:56 - 21:16
    - Oncology and HUB Tumor Organoid Models: 21:17 - 30:18
    - Q&A Session: 30:19 - 44:11
  • Segurança e Qualidade em Laboratórios - Impacto da vidraria Recorded: Sep 16 2020 91 mins
    Jerónimo Figueiredo - Business Operations Manager
    Segurança e Qualidade em Laboratórios - Impacto da vidraria
    Jerónimo Figueiredo - Business Operations Manager
Training for Life Science Researchers
The Corning Scientific Seminar Series is a series of free, online technical presentations that provide novel tips, best practices and proven techniques to help advance your research. Delivered by scientists to scientists, these one-hour broadcasts offer useful information and tips for lab technicians and researchers.

Embed in website or blog

Successfully added emails: 0
Remove all
  • Title: Enabling CAR-T Screening in 3D Tumor Spheroids
  • Live at: Mar 30 2017 4:00 pm
  • Presented by: Van Dang, D.V.M., Ph.D., Abhi Saharia, Ph. D., and Audrey Bergeron, Applications Scientist
  • From:
Your email has been sent.
or close